Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RelieVRx for TKA Pain
NCT04010266Completed
- Sponsor
- AppliedVR
- Start
- Mar 2021
- Primary completion
- Aug 2022
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by AppliedVR. Primary endpoints: Acute Postoperative Pain at 90 days and Opioid Consumption at 90 days. Started Mar 2021; status: completed.
Beyond the preview
Go deeper on NCT04010266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04010266.